Cost-effectiveness of an exercise and nutritional intervention versus usual nutritional care during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial.

Autor: Perrier L; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France. lionel.perrier@lyon.unicancer.fr.; GATE Lyon Saint-Etienne, UMR-CNRS 5824, University of Lyon, Lyon, France. lionel.perrier@lyon.unicancer.fr., Foucaut AM; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France.; Sorbonne Paris Cite, Educations and Health Practices Laboratory (LEPS) EA 3412, UFR SMBH, Paris 13 University, F-93017, Bobigny, France., Morelle M; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France.; GATE Lyon Saint-Etienne, UMR-CNRS 5824, University of Lyon, Lyon, France., Touillaud M; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France.; Cancer Research Center of Lyon, UMR Inserm 1052 CNRS 5286 CLB, Lyon, France., Kempf-Lépine AS; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France., Heinz D; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France., Gomez F; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France., Meyrand R; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France., Baudinet C; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France., Berthouze S; Inter-university Laboratory of Human Movement Biology EA 7424, Univ Lyon, University Claude Bernard Lyon 1, Villeurbanne, France., Reynes E; Laboratory of Vulnerabilities and Innovation in Sport EA 7428, FED 4272, Univ Lyon, University Claude Bernard Lyon 1, Villeurbanne, France., Carretier J; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France., Guillemaut S; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France., Pérol D; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France., Trédan O; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France., Philip T; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France., Bachmann P; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France., Fervers B; Léon Bérard Cancer Center, 28 rue Laënnec, 69008, Lyon, France.; Cancer Research Center of Lyon, UMR Inserm 1052 CNRS 5286 CLB, Lyon, France.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2020 Jun; Vol. 28 (6), pp. 2829-2842. Date of Electronic Publication: 2019 Nov 15.

[ISO 9001 certification of innovation and clinical research departments: Extending the scope of health assessment]

Autor: Sambou, C., Guillemaut, S., Morelle, M., Achache, A., Le Corroller, A.-G., Perol, David, Perrier, Lionel

Publikováno v: Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique
Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2017, 65 (2), pp.159-167. ⟨10.1016/j.respe.2016.12.026⟩
Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique
Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2017, 65 (2), pp.159-167. ⟨10.1016/j.respe.2016.12.026⟩

International audience; BACKGROUND:The International organization for standardization (ISO) is the world leader in providing industrial and commercial standards and certifications. Beyond medical devices, four French clinical research and innovation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::005b9cab2bdf368605bfb2884a46a116
https://www.hal.inserm.fr/inserm-02328562

A cost-effectiveness analysis of a 6-month physical activity program versus usual dietary care during adjuvant chemotherapy in breast cancer: An economic evaluation of the PASAPAS trial

Autor: Aude-Marie Foucaut, Touillaud, Marina S., Kempf-Lépine, A. S., Magali Morelle, Dominik Heinz, Sophie Berthouze, Eric Reynes, Julien Carretier, Guillemaut, S., Sylvie Chabaud, Bourne-Branchu, V., Lionel Perrier, Olivier Trédan, Béatrice Fervers, David Pérol, Patrick Bachmann

Publikováno v: 21th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Washington
21th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Washington, May 2016, Washington, United States
HAL

Présenté par Lionel Perrier; International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d0fc383ec9db4741b232de5477d7211a
https://shs.hal.science/halshs-01421080

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial.

Autor: Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, Netherlands., Cropet C; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France., Chevreau C; Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Boyle R; Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Tattersall M; Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Stacchiotti S; Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Italiano A; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France., Le Cesne A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Ferraresi V; Regina Elena National Cancer Institute, Rome, Italy., Penel N; Department of Medical Oncology, Centre Oscar Lambret, Université Lille 2, Lille, France., Duffaud F; Hôpital de la Timone, Aix-Marseille Université, Marseille, France., Cassier P; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Toulmonde M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Casali P; Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Taieb S; Medical Imaging Department, Centre Oscar Lambret, Université Lille 2, Lille, France., Guillemaut S; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France., Metzger S; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France., Pérol D; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France., Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France; University Claude Bernard Lyon 1, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2018 May; Vol. 19 (5), pp. 639-648. Date of Electronic Publication: 2018 Mar 20.